Instituto Universitario de Tecnologías Biomédicas
Instituto de investigación
J. Eugenio
Sanchez Criado
Publicaciones en las que colabora con J. Eugenio Sanchez Criado (9)
2006
-
Oestradiol-17β inhibits tamoxifen-induced LHRH self-priming blocking hormone-dependent and ligand-independent activation of the gonadotrope progesterone receptor in the rat
Journal of Endocrinology, Vol. 190, Núm. 1, pp. 73-84
-
The hypothalamus-pituitary-ovarian axis as a model system for the study of SERM effects: An overview of experimental and clinical studies
Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs (Springer Berlin Heidelberg), pp. 103-139
2003
-
Tamoxifen induces gonadotropin-releasing hormone self-priming through an estrogen-dependent progesterone receptor expression in the gonadotrope of the rat
Neuroendocrinology, Vol. 77, Núm. 6, pp. 425-435
2002
-
Tamoxifen but not other selective estrogen receptor modulators antagonizes estrogen actions on luteinizing hormone secretion while inducing gonadotropin-releasing hormone self-priming in the rat
Neuroendocrinology, Vol. 76, Núm. 4, pp. 203-213
2000
-
Luteinizing hormone secretion elicited in a ligand-independent activation of progesterone receptor manner at pituitary level in the rat: Differential effect of two selective estrogen receptor modulators
Neuroscience Letters, Vol. 289, Núm. 2, pp. 111-114
1999
-
Immunoreactive neurotensin in gonadotrophs and thyrotrophs is regulated by sex steroid hormones in the female rat
Journal of Neuroendocrinology, Vol. 11, Núm. 10, pp. 785-794
1998
-
Effect of RU486 injected on proestrous morning on LHRH, LH and 17β-estradiol secretion during the estrous cycle in rat
Journal of Physiology and Biochemistry, Vol. 54, Núm. 2, pp. 91-98
1994
-
Periovulatory LHRH, LH and FSH secretion in cyclic rats treated with RU486: Effects of exogenous LHRH and LHRH antagonist on LH and FSH secretion at early oestrus
Journal of Endocrinology, Vol. 141, Núm. 1, pp. 7-14
1989
-
Body growth and puberty remain unchanged in female rats after daily treatment with GRF (1-29) NH2
Endocrinologia, Vol. 36, Núm. 1, pp. 3-6